Found: 4
Select item for more details and to access through your institution.
The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease.
- Published in:
- Doklady Biochemistry & Biophysics, 2024, v. 515, n. 1, p. 48, doi. 10.1134/S1607672924700753
- By:
- Publication type:
- Article
Differential Diagnostics of Active Progressing Multiple Sclerosis Using a Fluorescent Biomarker with Resonance Energy Transfer.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2019, v. 167, n. 3, p. 329, doi. 10.1007/s10517-019-04520-1
- By:
- Publication type:
- Article
Differential Diagnostics of Active Progressing Multiple Sclerosis Using a Fluorescent Biomarker with Resonance Energy Transfer.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2019, v. 166, n. 6, p. 329, doi. 10.1007/s10517-019-04520-1
- By:
- Publication type:
- Article
A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Glatiramer Acetate 20 mg in Patients with Remitting Multiple Sclerosis: First-Year Study Results.
- Published in:
- Neuroscience & Behavioral Physiology, 2018, v. 48, n. 3, p. 351, doi. 10.1007/s11055-018-0570-z
- By:
- Publication type:
- Article